Dong Sung Kim, CEO of Celloid, was featured in an interview with BIOTIMES. Celloid’s groundbreaking 3D cell culture platform has started to gain attention in the advanced biotechnology industry.

Our innovative technology is enabling the scalable production of high-quality organoids with consistent reproducibility and relevance.

Go to link